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The gene coding for the small (S) envelope protein of hepatitis B virus was mutated to identify sequences important for
the envelopment of the nucleocapsid during morphogenesis of hepatitis delta virus (HDV) virions. This study was focused on
a domain of the S protein that is exposed in the cytoplasm during synthesis and thereby represented a good candidate for
interaction with the viral nucleocapsid during virion assembly. The mutations consisted of deletion/insertions spanning the
entire cytosolic domain of S between amino acid residues 24 and 80. Although the expression of mutants clustered between
residues 59 and 80 could not be obtained, we demonstrated that a large part of the cytosolic loop, from residues 29–47 and
49–59, does not contain motifs essential for production of hepatitis B virus subviral particles or HDV virions. However,
deletion of residues 24–28 led to the synthesis of S protein mutant, which was competent for secretion of subviral particles
but deficient for production of HDV. We concluded that the sequence between Arg-24 and Ile-28 located at the carboxyl
boundary of the transmembrane signal I for S contains residue or residues important for HDV particle assembly. © 1998
Academic Press
INTRODUCTION
Hepatitis delta virus (HDV) is a satellite of hepatitis B
virus (HBV), which is responsible for acute and chronic
infections with severe clinical consequences in humans
(Hollinger, 1996; Rizzetto et al., 1986). HDV depends on
the presence of HBV for the supply of envelope proteins
necessary to the formation of mature virions (Lai, 1995;
Taylor, 1996). The HDV particle consists of an outer
envelope of HBV origin and an inner nucleocapsid made
of a circular single-stranded RNA genome and two HDV-
encoded proteins, p24 and p27, that bear the hepatitis
delta antigen (HDAg). The large form, p27, which is es-
sential for particle formation, can be modified at its
carboxyl terminus by adjunction of a farnesyl group
whose role would be to anchor the nucleocapsid at the
endoplasmic reticulum (ER) membrane where envelope
proteins reside (Otto and Casey, 1996). The viral enve-
lope is made of lipids and three closely related trans-
membrane HBV envelope proteins designated large (L),
middle (M), and small (S) (Bonino et al., 1986). They are
encoded by a single open reading frame on the HBV
genome and are translated from different in-frame start
codons to a common stop codon. The L protein contains
three distinct regions, the N-terminal pre-S1, the central
pre-S2, and the C-terminal S domains, whereas the M
protein contains the pre-S2 and S regions, and the S
protein contains only the S domain that bears the hepa-
titis B surface antigen (HBsAg). A peculiar feature of S is
that it can be secreted as empty subviral particles, which
are produced in abundance during natural infection (Ga-
nem, 1996). The S polypeptide can also package HDV
nucleocapsids in the absence of M and L to assemble
HDV particles identical to mature virions, except for in-
fectivity, which requires the presence of L in the enve-
lope (Sureau et al., 1993; Wang et al., 1991). In contrast,
S cannot package the HBV nucleocapsid in the absence
of L because the L pre-S domain contains a motif essen-
tial for this process (Bruss, 1997; Bruss and Ganem,
1991). Thus the 226-amino acid residues of the S protein
sequence contain all the information necessary for its
own secretion and that of HDV. It is generally admitted
that synthesis occurs at the ER membrane where glyco-
sylated (gp27) or nonglycosylated (p24) S proteins an-
chor and oligomerize (Huovila et al., 1992). They are
transported via vesicles toward the Golgi compartment
and are secreted as empty 20-nm particles, presumably
after budding at the pre-Golgi membrane into the lumen.
The topology of S across the ER membrane during syn-
thesis has been described in some detail (Eble et al.,
1986, 1987). The amino terminus (residues 1–3) is ex-
posed at the luminal side of the ER membrane, followed
by a transmembrane signal (signal I) between residues 4
and 28, a cytosolic loop between residues 28 and 80, and
a second transmembrane signal (signal II) that anchors
the protein into the membrane in the opposite direction
with respect to signal I. The distal region, between res-
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idues 100 and 164, also referred to as antigenic loop,
contains the major epitopes of the S protein and is found
in the luminal compartment or at the outside of secreted
particles. Finally, the topology of the carboxyl-terminal
domain between residues 164 and 226 is not precisely
known. The major part, from residues 164–221, is pre-
dicted to be hydrophobic and to contain transmembrane
helices (Stirk et al., 1992).
In this study, we sought to identify domains of the S
polypeptide that are important for envelopment of HDV
nucleocapsid. We chose to focus our investigation on the
region of S that is located between residues 24 and 80
because it is exposed on the cytosolic side of the ER
membrane, a disposition prone to interaction with the
HDV nucleocapsid during virion assembly. To this end,
we constructed a series of deletion/insertion mutations
and single amino acid substitutions in the DNA coding
region for S and examined their impact on synthesis and
secretion of subviral and HDV particles. The mutant vec-
tors were introduced along with a HDV expression vector
by transfection into permissive HuH-7 cells, and the
synthesis and secretion of subviral and HDV particles
were monitored. We demonstrated that most of the cyto-
solic loop of the S protein, from residues 29–47 and
49–59, could tolerate deletions or substitutions without
impairment for secretion of subviral or HDV particles. We
also demonstrated that a deletion at the carboxyl termi-
nus of signal I between residues 24 and 28 led to a
drastic reduction in the capacity of S for assembly of
enveloped HDV without affecting subviral particle secre-
tion.
RESULTS
Enveloped HDV RNA-containing particles can be pro-
duced in HuH-7 cells after cotransfection with an expres-
sion vector for production of HDV RNA and nucleocapsid
proteins and a vector for expression of the S HBV enve-
lope protein (Sureau et al., 1994). Here we used S mu-
tants coexpressed with HDV proteins and RNA in HuH-7
cells to identify sequences of S that are involved in the
assembly and secretion of HDV. We first constructed a
series of progressive deletions of five-amino acid resi-
dues in the entire cytosolic loop (amino acid residues
24–80) of S with the exception of Cys residues at position
48, 65, and 69, which are essential for secretion
(Mangold and Streeck, 1993). Although the hydrophobic
transmembrane signal I extends from residue 4 to 28, we
decided to include a deletion encompassing positively
charged Arg-24, which is unlikely to be inserted in lipid
membrane. Each deleted sequence was substituted with
a Lys-Leu linker sequence as described in Materials and
Methods. The mutant vectors, referred to as KL mutants,
were designated by the positions of the deleted residues
in the S sequence and by the letters KL for Lys-leu as
indicated in Fig. 1. A series of mutants referred to as GA
mutants consisted of five-residue deletions and substi-
tutions with the Gly-Ala sequence. They covered the
region between amino acid residues 54–80. Mutant D29–
47Glo consisted of a substitution of the Met-1 to Gly-19
sequence from chimpanzee a1-globin for the Pro-29–
Val-47 sequence of S. This a-globin polypeptide was
chosen because it substitutes for a polypeptide of similar
length, its sequence has no homology with that of S, it
does not contain any topogenic signal, and it has been
used in previous studies to map the transmembrane
signals of HBV envelope proteins (Eble et al., 1986). It
was cloned in plasmid pT7HB2.7, which directs the syn-
thesis of all three envelope proteins: S, M, and L (Sureau
et al., 1994). The resulting mutant vector, pT7HB2.7–
172425, therefore directs the synthesis of mutant S, M,
and L proteins. Finally, single-amino acid substitution
mutants were obtained for Gly-71, Trp-74, and Arg-78 by
replacement with Ala, Phe, and Lys, respectively, and a
triple mutant referred to as R73L/M75T/R79L was con-
structed by substitution of Arg-73, Met-75, and Arg-79
with Leu, Thr, and Leu, respectively.
Effect of deletion/substitution and single-amino acid
substitution mutations on secretion of subviral HBV
particles
Expression of wild-type and mutant S genes were
examined by transient transfection of HuH-7 cells with
p123 and each S mutant expression vector. Transfected
cells were labeled for 24 h with [35S]Cys and [35S]Met,
and the envelope proteins from the cell lysates and
supernatants were immunoprecipitated with R247 anti-S
antibodies and analyzed by SDS-PAGE and autoradiog-
raphy. R247 antibodies had been raised in rabbit against
a reduced, denatured preparation of S protein and there-
fore were likely to recognize a linear epitope. As shown
on Fig. 2, transfection of HuH-7 cells with wild-type (WT)
HBV DNA led to the synthesis of S proteins under non-
glycosylated and glycosylated forms: p24 (24 kDa) and
gp27 (27 kDa), respectively. Proteins were found in both
cell lysate and supernatant as evidence of an efficient
secretion. As observed previously, the glycosylated form
has an apparent molecular mass slightly higher in the
supernatant as a result of modifications of N-linked gly-
cans in the Golgi compartment before secretion (Bruss,
1997; Mangold and Streeck, 1993). Mutants D24–28KL,
D39–43KL, and D44–47KL were competent for synthesis
and secretion at levels similar to that of WT, whereas
mutants D34–38KL and D49–53KL detected at WT level
in the cell lysates were deficient for secretion. Interest-
ingly, mutant D34–38KL was detected as nonglycosy-
lated polypeptide although the deletion is .100 amino
acid residues upstream of the N-glycosylation site at
Asn-146. The deletion may have led to misfolding and
retention of the protein at the ER membrane under a
transmembrane topology incompatible with glycosyla-
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tion. Mutants D70–75KL and D76–80KL were detected
only at low levels in the cell lysates, whereas mutants
D29–33KL, D54–58KL, and D59–64KL failed to be de-
tected even after a prolonged exposure of the autoradio-
gram. It is noteworthy that mutations D54–58KL and
D59–64KL removed a Ser-Pro-Thr-Ser repeat. Moreover,
His-60, which is essential for secretion (Mangold and
Streeck, 1993), was deleted in D59–64KL.
To ascertain that the lack of detection for some mutants
was not a consequence of deleting an epitope recognized
by R247 anti-S, we performed immunoprecipitation assay
using Cal anti-S antibodies raised against intact HBV sub-
viral particles. As shown in Fig. 2B, mutant D54–58KL was
detected in cell lysate and culture medium at a level com-
parable to that of WT and D59–64KL was present in cell
lysate only. This result indicated that D54–58KL mutant was
indeed expressed and secreted and that R247 antibodies
probably recognized a linear epitope encompassing the
Gln-54-to-Ser-64 sequence. Mutants D70–75KL and D76–
80KL were detected at low levels with Cal anti-S antibodies
in cell lysates but not visible in the culture medium. This
pattern was similar to that observed with R247 antibodies.
It thus was concluded that KL deletion/substitutions in
these regions were deleterious to S expression. Transfec-
tion with env-negative plasmid DNA led to the synthesis of
a truncated S protein that was detected with Cal anti-S
antibodies in the cell lysate only. The translation of this
polypeptide is probably initiated at Met-75 as observed
previously (Prange et al., 1992), downstream of the motif
recognized by R 247 antibodies. Mutant D29–47Glo, which
contains a substitution of the N-terminal residues Met-1 to
Gly-19 of the chimpanzee a-globin sequence for the Pro-29
to Val-47 sequence, was synthesized and secreted at WT
level (Fig. 2A). Taken together, these results indicate that
the sequence from residue 29 to 58 (with the exception of
Cys-48) does not contain motifs essential for synthesis and
secretion of subviral particles.
To eliminate the possibility that the Lys-Leu substitu-
tion, rather than the deletion, had an inhibitory effect on
synthesis or secretion of mutants covering residues 59–
80, we constructed a new panel of deletion/insertions
where the Lys-Leu sequence was changed to Gly-Ala.
Deletion positions were slightly modified to avoid re-
moval of His-60, an amino acid essential for S secretion
(Mangold and Streeck, 1993). Mutants designated D54–
59GA, D61–64GA, D66–68GA, D70–75GA, and D76–80GA
FIG. 1. Schematic representation of mutant S proteins. Plasmid p123 and S protein are depicted by horizontal thin lines. HBV envelope protein open
reading frame is divided in pre-S1, pre-S2, and S domains. Single-base substitutions converted ATG Met start codons to ACG Thr codons for
expression of the S protein only. The S proteins were expressed from the S HBV promoter in the pre-S1 region. Open boxes represent hydrophobic
transmembrane regions in the S protein. Transmembrane signals I and II are indicated. The name and sequence of each mutant, including the
position of the first and last residues of the deleted sequence, are indicated. The letters KL or GA correspond to an insertion of Lys-Leu or Gly-Ala,
respectively, at the site of deletion. The bottom lanes correspond to single- and triple-amino acid mutants indicating the position and nature of the
substitutions.
178 JENNA AND SUREAU
were tested in HuH-7 cells by transient transfection,
metabolic labeling, and immunoprecipitation. After im-
munoprecipitation with R247 anti-S antibodies and anal-
ysis by SDS–PAGE, we observed that the substitution of
Gly-Ala for Lys-Leu did not improve subviral particle
synthesis or secretion (Fig. 3). Indeed, all GA mutants
displayed phenotypes similar to those of KL mutants.
Mutant D54–59GA was undetectable, whereas mutants
D61–64GA, D66–68GA, D70–75GA ,and D76–80GA were
poorly expressed and deficient for secretion as evi-
denced by the presence of a weak signal in the cell
lysate only. We concluded that short deletions in the
carboxyl terminus of the cytosolic loop of S are detrimen-
tal to synthesis or secretion of subviral particles. The
detection of D54–59GA at WT level in cell lysate and
supernatant using Cal anti-S antibodies and that of D61–
64GA with R247 antibodies indicated that the linear
FIG. 2. Examination of WT and KL or Glo deletion/insertion mutant
S proteins expressed in HuH-7 cells. Six days after transfection of
0.5 3 106 HuH-7 cells with 2 mg of p123 DNA or its derivatives,
transfected cells were labeled with 200 mCi of [35S]Cys–[35S] Met for
24 h. After labeling, cell lysates (c) and supernatants (s) were
immunoprecipitated with rabbit R 247 anti-S antibodies (A) or Cal
anti-S antibodies (B). One half of each immunoprecipitate was an-
alyzed by SDS–PAGE. After electrophoresis, the gel was fixed,
soaked in Amplify solution (Amersham), dried, and subjected to
fluorography at 270°C for 48 h. The migration positions of glycosy-
lated (gp27) and nonglycosylated (p24) S proteins are indicated. EN
indicates env-negative plasmid.
FIG. 3. Examination of WT and GA mutant S proteins expressed in
HuH-7 cells. Six days after transfection of 0.5 3 106 HuH-7 cells with 2
mg of p123 DNA or its derivatives, transfected cells were labeled with
200 mCi of [35S]Cys–[35S]Met for 24 h. After labeling, cell lysates (c) and
supernatants (s) were immunoprecipitated with rabbit R 247 anti-S
antibodies (A) or Cal anti-S antibodies (B). One half of each immuno-
precipitate was analyzed as described in the legend to Fig. 2. The
migration positions of glycosylated (gp27) and nonglycosylated (p24) S
proteins are indicated. EN indicates env-negative.
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epitope recognized by R247 antibodies is determined by
residues 54–59.
As a further attempt to obtain secretion competent S
mutants within residues 60–80, site-directed mutagene-
sis was used to generate single-amino acid substitu-
tions. Substitutions were carried out on residues Gly-71,
Arg-73, Trp-74, Met-75, Arg-78, and Arg-79, which are
conserved in the S protein of the HBV-related woodchuck
hepatitis virus (WHV), a virus capable of providing helper
functions for replication of HDV in WHV-infected wood-
chuck (Ponzetto et al., 1984). A triple mutant was con-
structed by substituting Leu, Thr, and Leu residues to
Arg-73, Met-75, and Arg-79, respectively. The latter resi-
dues are conserved among all HBV genotypes and WHV,
but they are substituted by Leu, Thr, and Leu, respec-
tively, in the S protein of the duck hepatitis B virus
(DHBV), an avian hepadnavirus whose competence for
envelopment of HDV nucleocapsid has not been demon-
strated (Mason et al., 1980). After transfection in HuH-7
cells and immunoprecipitation with anti-S antibodies, we
observed that mutants G71A and W74F had a WT phe-
notype with regard to synthesis and secretion, whereas
R78K was significantly altered for synthesis and triple-
mutant R73L/M75T/R79L failed to be detected (Fig. 4).
Effect of S protein mutations on secretion of
enveloped HDV RNA-containing particles
For production of enveloped HDV RNA-containing
particles, HuH-7 cells were cotransfected with S ex-
pression vector p123 or its derivatives and the HDV
expression vector pSVLD3 (Kuo et al., 1989). Culture
supernatant was harvested on days 6, 9, 12, and 15
posttransfection (p.t.), and viral particles were precip-
itated in the presence of polyethylene glycol (PEG)
before analysis for S protein by immunoblotting with
Cal anti-S antibodies and for HDV RNA by agarose gel
electrophoresis and blot hybridization. Cells also were
harvested on day 15 for analysis of intracellular HDV
RNA. The control experiment was performed by co-
transfection of HuH-7 cells with pSVLD3 and env-
negative HBV plasmid pT7HB2.767. As shown in Figs.
5 and 6, there was no evidence for the release of
enveloped HDV RNA-containing particle in the ab-
sence of HBV envelope proteins as already demon-
FIG. 5. Detection of HDV RNA-containing particles in culture fluids
from cells transfected with pSVLD3 plasmid DNA and p123 plasmid or
mutants DNA. (A) Immunoblot analysis of S proteins extracted from
culture fluids from 0.5 3 106 HuH-7 cells at days 6, 9, 12, and 15 after
transfection with a mixture of 0.6 mg of pSVLD3 plasmid DNA and 1.4
mg of WT, env-negative (EN), or mutants HBV plasmid DNA. Particles
were sedimented by precipitation in the presence of 9% PEG from 200
ml of culture medium and disrupted in Laemmli’s sample buffer con-
taining 2% SDS and 2% b-mercaptoethanol and heated at 100°C for 5
min. Proteins were separated on a 12% acrylamide gel, transferred to a
PVDF membrane, and probed with Cal anti-S antibody (1:1000). (B)
Cellular RNA was extracted from HuH-7 cells harvested at day 15 p.t.
using the acid phenol purification procedure. Then 5 mg of total RNA
was separated on agarose gel and analyzed for the presence HDV RNA
after transfer to nylon membrane and hybridization to a genomic strand
specific 32P-labeled HDV RNA probe. After hybridization, filters were
washed, dried, and autoradiographed at 270°C for 16 h with an
intensifying screen. The size in kb of HDV genomic RNA is indicated.
(C) Particles sedimented by precipitation in the presence of 9% PEG
from 500 ml of culture medium were disrupted in RNazol, and RNA was
purified. RNA was analyzed by agarose gel electrophoresis transfer
and hybridization to a genomic strand specific 32P-labeled HDV RNA
probe as in Fig. 5(B).
FIG. 4. Examination of WT and single-substitution mutant S proteins
expressed in HuH-7 cells. Six days after transfection of 0.5 3 106 HuH-7
cells with 2 mg of p123 DNA or point mutations derivatives, transfected
cells were labeled with 200 mCi of [35S]Cys–[35S]Met for 24 h. After
labeling, cell lysates (c) and supernatants (s) were immunoprecipitated
with rabbit R 247 anti-S antibodies. One half of each immunoprecipitate
was analyzed as described in the legend to Fig. 2. The migration
positions of glycosylated (gp27) and nonglycosylated (p24) S proteins
are indicated. EN indicates env-negative.
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strated (Ryu et al., 1992). Mutants D39–43KL, D44–
47KL, D49–53KL, D54–58KL, and D54–59GA that were
competent for subviral particle secretion were also
capable of assisting in HDV nucleocapsid envelop-
ment as indicated by the presence of viral RNA in PEG
precipitates. Interestingly, mutant D24–28KL, which
exhibited a WT efficiency for subviral particle secre-
tion, was deficient for HDV assembly as judged by the
very low amount of viral RNA in the PEG precipitate. By
comparison with a known amount of synthetic HDV
RNA, we estimated the amount of viral RNA at 5 pg
(5 3 106 genome equivalents) per milliliter of culture
medium for D24–28KL-coated particles and at 100 pg
(1 3 108 genome equivalents) per milliliter for WT
coated particles, whereas Western blot analysis re-
vealed that culture supernatant from both mutant or
WT transfected cells contained ;80 ng (2 3 1010
empty particle equivalents) per milliliter of S proteins.
If we assume that a mature HDV particle contains only
one copy of HDV RNA, we can estimate the ratio of
HDV virions to empty particles at 1:200. Substitution
mutant D29–47Glo was competent for HDV envelop-
ment as judged by the presence of viral RNA in the
PEG precipitate at WT level. This result indicates that
the sequence from residues 29–47 does not contain a
motif necessary for envelopment of HDV. Mutant W74F
had a phenotype close to that of WT with regard to
secretion of subviral particles, whereas G71A was
secreted to a slightly lower level. However, both were
efficient in assisting in the production of HDV RNA-
containing particles (Fig. 6). Taken together, our re-
sults indicate that the amino-terminal two thirds of the
cytosolic loop from residues 29 to 59 (except for Cys-
48) is dispensable for subviral and HDV particle se-
cretion in vitro. Unfortunately, the carboxyl-terminal
third, from residues 60 to 80, could not be probed for
HDV envelopment using our assay conditions because
most of the mutants covering this domain were either
not stable or not secreted. Finally, D24–28KL repre-
sented the only mutant that is deficient for envelop-
ment or stability of HDV while displaying a WT pheno-
type with regard to subviral particle secretion.
FIG. 6. Detection of HDV RNA-containing particles in culture fluids from cells transfected with pSVLD3 plasmid DNA and p123 plasmid or mutants
DNA. (A) Immunoblot analysis of S proteins extracted from culture fluids of 0.5 3 106 HuH-7 cells at days 6, 9, 12, and 15 after transfection with a
mixture of 0.6 mg of pSVLD3 plasmid DNA and 1.4 mg of WT, env-negative (EN), or mutant DNA. Particles were sedimented by precipitation in the
presence of 9% PEG from 200 ml of culture medium and analyzed by SDS–PAGE and immunoblotting with Cal anti-S antibody (1:1000) as in Fig. 5.
(B) Cellular RNA was extracted from HuH-7 cells harvested at day 15 p.t., and 5 mg was analyzed by gel electrophoresis and hybridization to a genomic
strand specific 32P-labeled HDV RNA probe. (C) RNA purified from particles concentrated by precipitation with PEG from 500 ml of culture medium
was analyzed by gel electrophoresis and hybridization to a genomic strand specific 32P-labeled HDV RNA probe. The gel migration positions of
intracellular or extracellular genomic HDV RNA (1.7 kb) and S proteins (p24 and gp27) are indicated.
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Characterization of the D24–28 mutant defective for
assembly of enveloped HDV RNA-containing particles
Mutant D24–28KL enveloped virions were character-
ized by isopycnic centrifugation in cesium chloride gra-
dient to (1) verify their buoyant density, (2) ascertain that
traces of RNA that were detected in the PEG precipitate
were indeed part of enveloped HDV particles, and (3)
better quantify both S protein and viral RNA. After cen-
trifugation and fractionation of the gradient, S protein and
genomic HDV RNA were detected in fractions surround-
ing 1.20 g/cm3 density for both WT and D24–28KL parti-
cles, although only traces of RNA were visible in mutant
virions (Figs. 7B and 7C). As expected, there was no
trace of HDV RNA in the control experiment conducted
with env-negative plasmid pT7HB2.767 (Fig. 7A), implying
that HDV RNA-containing nucleocapsids are not se-
creted or that if they are, then they are not stable in the
absence of S, as already demonstrated (Ryu et al., 1992).
By measurement of HDV RNA signals in WT and D24–
28KL particle extracts (standardized for S protein con-
tent) after blot hybridization and analysis with a densi-
tometer, we confirmed the efficiency of D24–28KL for
envelopment of HDV RNA-containing particles to be ,5%
that of WT. We concluded that D24–28KL S indeed rep-
resented a HDV assembly-defective mutant with WT
competence for subviral particles assembly and secre-
tion but with a .20-fold reduction in its capacity for
production of stable HDV particles.
DISCUSSION
The results presented here indicate that the carboxyl
terminus of transmembrane signal I of S contains resi-
due or residues important for nucleocapsid envelopment
of HDV and that the amino-terminal part (residues 28–47
and 49–59) of the cytosolic loop does not include se-
quences essential for this process. We had made the
choice to investigate the cytosolic loop of S (residues
24–80) in priority for its role in HDV morphogenesis
because its position in the cytoplasm during synthesis is
compatible with a direct interaction with the nucleocap-
sid. In comparison, the antigenic loop (residues 100–164)
adopts a luminal topology and is exposed at the surface
of virions. It thus did not appear adequate for binding to
the nucleocapsid unless one takes into account an al-
ternative topology proposed by Prange and Streeck
(1995), who claimed that the antigenic loop could face
the cytoplasm in a fraction of S proteins corresponding to
the nonglycosylated molecules. In such molecules, the
interaction with the nucleocapsid could indeed be medi-
ated by the antigenic loop. The topology of transmem-
brane signal I and II, located within sequences 4–28 and
80–100, respectively, does not appear to be compatible
with their binding to the nucleocapsid because of their
association with the lipid membrane. In addition, they are
essential for subviral particle secretion as demonstrated
by previous studies, and their sequence thus is not
amenable to extensive mutations.
Although a complete replacement of the residue 48–59
sequence was not done, the results obtained with mu-
tants D29–47Glo, D49–53KL, D54–58KL, and D54–59GA
demonstrate that the amino-terminal two thirds of the
FIG. 7. Purification of HDV RNA-containing particles by centrifugation
in cesium chloride gradient. Culture medium from HuH-7 cells were
collected at days 6, 9, 12, and 15 after transfection of 0.5 3 106 cells
with 0.6 mg of pSVLD3 plasmid DNA and 1.4 mg of WT, env-negative
(EN), or D24–28KL plasmid DNA. Particles were concentrated from 5 ml
of culture medium by precipitation in the presence of PEG and sub-
jected to centrifugation to equilibrium in 12 ml cesium chloride gradi-
ents. Fractions were collected from the bottom of the tube and proteins
were analyzed from one fourth of each 1-ml fraction by immunoblotting
with R 247 anti-S antibody (1:1000). RNA was extracted from the same
volume of each fraction for analysis by agarose gel electrophoresis and
blot hybridization using a genomic strand specific 32P-labeled HDV
RNA probe. The gel migration positions of genomic HDV RNA (1.7 kb)
and S proteins (p24 and gp27) are indicated. The numbering (4–11) of
each fraction is indicated. Fractions 8 and 9 correspond to densities
1.22 and 1.18 g/cm3, respectively.
182 JENNA AND SUREAU
cytosolic loop, from residues 29 to 59, do not contain any
discrete motif essential to subviral or HDV particles se-
cretion, with the exception of Cys-48, which is essential
for S secretion as reported previously (Mangold and
Streeck, 1993). Interestingly, deletions present in D29–
33KL and D34–38KL mutants were deleterious to synthe-
sis, glycosylation, or secretion, whereas substitution of
the same region, up to residue 47, with an unrelated
sequence of the same length as in D29–47Glo, led to
correct expression and secretion. This indicates that the
region from Pro-29 to Val-47 does not contain motifs
essential for S secretion, but as suggested by Prange et
al. (1992), a minimum sequence length seems to be
required to ensure a folding of the S protein compatible
with glycosylation and secretion.
Although transmembrane signal I is predicted to re-
side between residues 4 and 28, we chose to construct
a mutant including Arg-24 because positively charged
residues such as arginine are not usually associated to
lipid membrane. In addition, the sequence Arg-Ile-Leu-
Thr-Ile corresponding to the deletion in D24–28KL is
located at the carboxyl terminus of transmembrane sig-
nal I, a position usually important for the proper orienta-
tion of the polypeptide in the ER membrane. The net
result of substituting Lys-Leu for Arg-Ile-Leu-Thr-Ile ap-
pears to be the removal of Ile-Leu-Thr because the sub-
stitution of a lysine residue for arginine at position 24 is
observed in the WHV S protein, which is competent for
HDV nucleocapsid envelopment. It thus will be interest-
ing to test the effect of a single amino acid substitution at
Thr-27 on HDV assembly.
The strategy used in our study did not allow the exact
function of the sequence 24–28 to be defined; in partic-
ular, direct binding of S to the nucleocapsid through
residues in this sequence is not demonstrated. In addi-
tion, our assay does not distinguish between a defect in
the assembly of HDV nucleocapsid into envelopes and a
defect in secretion or stability of progeny virions. It is
quite possible that mutant D24–28KL lacks a nucleocap-
sid binding motif or part of a nonlinear binding motif
involving sequences located elsewhere in the S mole-
cule. Deletion may also have affected the overall confor-
mation of S that would interfere with the proper presen-
tation of a nucleocapsid binding domain without affect-
ing morphogenesis and secretion of subviral particles.
The interference may occur through some sort of steric
hindrance or modification of lateral S–S interactions with
consequences on the assembly or stability of HDV only.
Deletion of residues 24–28 may result in secretion of
unstable HDV particles that would not be detected under
our assay conditions because a weaken viral envelope
could lead to the release of naked nucleocapsid followed
by rapid degradation of the viral RNA. However, the
integrity of D24–28KL subviral particles seems to be
maintained because their physical characteristics, as
observed with isopycnic centrifugation analysis in a ce-
sium chloride gradient, are indistinguishable from those
of WT. In addition, the immunoprecipitation analysis pro-
vided evidence that D24–28KL S proteins had WT prop-
erties with regard to glycosylation, secretion, and anti-
genicity. Although the defect for HDV envelopment ob-
served in D24–28KL may result from changes in
conformation in a region removed from the position of
the mutation, it is quite possible that residues within
sequence 24–28 are involved in direct interaction with
the nucleocapsid. Direct interaction between nucleocap-
sid and envelope proteins has been described in the
assembly process of alphaviruses (Lopez et al., 1994;
Metsikko¨ and Garoff, 1990). In this model, virion forma-
tion occurs when nucleocapsids, previously assembled
in the cytoplasm, bud through the plasma membrane
after interaction with the envelope glycoproteins. Such
interactions are also thought to drive the assembly of
HBV virion, but the proof for its requirement has not yet
been established. Using a genetic approach similar to
ours, Bruss (1997) has shown that assembly of HBV is
dependent on the pre-S sequence (residues 103–124) of
the L protein, and previous experiments indicated that
synthetic peptides encompassing the 103–124 pre-S se-
quence could bind specifically to HBV nucleocapsid
(Poisson et al., 1997). These results may indicate that
direct binding between HBV nucleocapsid and the pre-S
polypeptide of L is necessary for budding of HBV virions.
In agreement with our results, Hourioux et al. (1998)
reported that synthetic peptides corresponding to resi-
dues 31–55 of S had no specific binding capacity to delta
protein p24 or p27. However, the same study revealed a
specific affinity between delta proteins and a synthetic
peptide corresponding to residues 56–80. Unfortunately,
this domain could not be probed in our assay conditions
because most of the mutations in this sequence were
deleterious for synthesis or secretion.
In summary, our study reveals the importance of res-
idues 24–28 of the S protein for the production of HDV
but does not demonstrate their contribution to a direct
interaction with the nucleocapsid. It does demonstrate,
however, that sequences 28–47 and 49–59 do not con-
tain any motif essential for HDV morphogenesis, but it
remains inconclusive concerning the carboxyl terminus,
residues 60–80, of the cytosolic loop. Further experi-
ments will be needed to investigate this and other re-
gions of the S protein; in particular, its carboxyl terminus
may contain additional HDV envelopment signals (Chen
et al., 1993; Wang et al., 1996).
MATERIALS AND METHODS
For production of HBV S envelope proteins in HuH-7
cells, we used the expression vector p123. It was a
derivative of pT7HB2.7 (Sureau et al., 1994) that contains
a BglII (nucleotide2840)-to-BglII (nucleotide1987) frag-
ment of HBV DNA (D genotype, ayw3 subtype), including
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the pre-S1-pre-S2-S gene in which the ATG start codons
for the L and M proteins were changed to ACG to ablate
the expression of L and M and allow for the expression
of WT S only. Control plasmid pT7HB2.767, also referred
to as env-negative, is a derivative of pT7HB2.7 in which
the ATG start codons for the L, M, and S proteins were
mutated to ACG to eliminate the expression of all three
envelope proteins. Deletion/substitutions were carried
out on p123 using the PCR technique with two comple-
mentary mutagenic oligonucleotides according to the
overlap extension method (Higuchi et al., 1988; Horten et
al., 1989). The overlapping oligonucleotides contained a
15-nucleotide deletion corresponding to five-amino acid
residues in the S gene and a six-nucleotide insertion for
the HindIII restriction enzyme cleavage site (correspond-
ing to residues lysine and leucine) to provide easy de-
tection and tracking of the mutation. The resulting S
protein mutants contained a five-residue deletion that
was replaced by insertion of the Lys-Leu sequence (see
Fig. 1). They were designated by the numbers of the first
and last residues of the deleted sequence and the letters
K and L for the substitution with the Lys-Leu sequence.
Single amino acid substitutions also were carried out
using the PCR overlap extension method. The mutations
were designated by the one-letter code of the WT amino
acid followed by its position in S and by the substituted
amino acid. Mutant D29–47Glo consisted of a substitu-
tion of the N-terminal sequence (residues 1–19) of the
chimpanzee a1-globin protein for the residues 29–47 of
the S protein (Eble et al., 1986; Liebhaber and Begley,
1983). PCR-generated fragments were cloned in
pT7HB2.7 and sequenced using the dideoxy method on
double-stranded templates with Sequenase (Amer-
sham). Clones containing the desired mutations within
the PCR-generated fragments were selected and used
for subsequent transfections. For production of HDAg
proteins and replication of HDV RNA, we used the re-
combinant plasmid pSVLD3, which contains a head-to-
tail trimer of full-length HDV cDNA for expression of HDV
genomic RNA under the control of the SV40 late pro-
moter (Kuo et al., 1989; Sureau et al., 1989).
Culture and transfection of HuH-7 cells
HuH-7 cells were maintained in DMEM/F-12 supple-
mented with 10% FBS. For production of HDV particles,
cells were transfected with a mixture of plasmid pSVLD3
for replication of HDV RNA and production of HDV pro-
teins and the HBV recombinant plasmid p123 or deriva-
tives for production of the WT or mutant S proteins.
Transfection was carried out using lipofectin according
to the manufacturer’s directions (Life Technologies).
Cells were seeded at 0.5 3 106/35-mm-diameter well
and transfected at 24 h postseeding. Cells were exposed
to the DNA–lipofectin mixture for 16 h and washed with
PBS before incubation in fresh medium. For analysis of S
protein expression by immunoprecipitation, transfections
were carried out with 2 mg of p123 DNA or its derivatives
per 0.5 3 106 cells/well and cells were labeled at day
6 p.t. For production of HDV particles, 0.5 3 106 cells
were cotransfected with 0.6 mg of pSVLD3 DNA and 1.4
mg of p123 DNA or its derivatives. Culture medium was
harvested on days 6, 9, 12, and 15 p.t. and analyzed for
the presence of envelope proteins and HDV RNA.
Preparation and characterization of particles
produced by HuH-7 cells
Culture fluids harvested on days 6, 9, 12, and 15 after
transfection were used for purification of viral particles.
They were clarified by centrifugation at 4000g at 4°C for
30 min. Viral particles were precipitated by addition of
PEG to a final concentration of 9%. After incubation at
4°C for 1 h, the precipitates were collected by centrifu-
gation at 10,000g for 20 min at 4°C. One half of the
precipitate was resuspended in protein gel loading
buffer and frozen at 270°C before protein analysis by
SDS–PAGE and immunoblotting with anti-S antibodies.
One half was resuspended in RNAzol (Eurobio) for RNA
extraction according to the guanidine thiocyanate-acid
phenol method (Chomczynski and Sacchi, 1987).
Metabolic labeling and immunoprecipitation
Six days after transfection, HuH-7 cells were washed
twice with PBS and incubated for 1 h at 37°C with 10%
CO2 in Met/Cys-free DMEM supplemented with 10% di-
alyzed FBS. The medium then was replaced with 1 ml of
fresh Met/Cys-free medium supplemented with 200
mCi/ml of [35S]Cys–[35S]Met (1168 Ci/mmol; Promix [35S]-
Label, Amersham), and cells were incubated for 24 h at
37°C and 10% CO2. After labeling, the culture medium
was collected and clarified by centrifugation at 4000g for
30 min at 4°C. Cells were washed three times with cold
0.1 M Tris–HCl (pH 8.0) and 0.1 M NaCl and lysed in 3 ml
of 0.1 M Tris–HCl (pH 8.0), 0.1 M NaCl, 10 mM EDTA, 0.5%
Nonidet P-40, and 2 mM phenylmethylsulfonyl fluoride for
15 min at 0°C. Cell lysates were clarified by centrifuga-
tion at 4000g for 30 min at 4°C. For immunoprecipitation,
clarified lysates and supernatants were adjusted to 0.1 M
NaCl, 20 mM EDTA, 0.1% sodium deoxycholate, 0.5%
Nonidet P-40, 0.5% Triton X-100, and 0.1% SDS and incu-
bated for 16 h at 4°C with R 247 or Cal anti-S antibodies.
R247 anti-S antibodies had been raised in rabbit against
reduced, denatured, and gel-purified S protein derived
from a pool of human HBV infectious serum, and Cal
anti-S antibodies (Calbiochem) had been prepared by
injection into rabbit of purified intact particles. This latter
preparation, which is no longer available from the man-
ufacturer, was sparingly used in this study. Immune com-
plexes were isolated after incubation for 1 h at 4°C with
a 10% (wt/vol) suspension of Protein A–Sepharose (Sig-
ma). The beads were washed three times with 10 mM
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Tris–HCl (pH 7.5), 150 mM NaCl, 1% sodium deoxy-
cholate, 1% Triton X-100, and 0.2% SDS and twice with
0.125 M Tris–HCl (pH 6.8). Proteins were eluted from the
beads by boiling in 50 mM Tris–HCl (pH 6.8), 2% SDS,
0.1% bromphenol blue, 10% glycerol, and 5% b-mercap-
toethanol. After electrophoresis on SDS–PAGE, the gel
was fixed, soaked in Amplify solution (Amersham), dried,
and subjected to fluorography at 270°C.
Detection of HDV RNA
Extraction of RNA from viral particles precipitated in
the presence of PEG was carried out according to the
guanidinium thiocyanate-acid phenol-chloroform extrac-
tion method (Chomczynski and Sacchi, 1987) after resus-
pension of PEG precipitates in RNAzol. RNA samples
were subjected to electrophoresis through a 1.2% aga-
rose–2.2 M formaldehyde gel and then transferred to
nylon membrane (Boehringer-Mannheim) before hybrid-
ization to an HDV-specific RNA probe. Full-length 32P-
labeled RNA riboprobes were synthesized by in vitro
transcription for specific detection of genomic HDV RNA
using the T7 RNA polymerase. A preparation of genomic
HDV RNA standard was used to estimate the number of
HDV molecules in RNA samples.
Detection of HBV envelope proteins by
immunoblotting analysis
Particles sedimented from the culture medium were
disrupted by boiling for 5 min in 50 mM Tris–HCl (pH 6.8),
2% SDS, 0.1% bromphenol blue, 10% glycerol, and 5%
b-mercaptoethanol. Proteins were separated by SDS–
PAGE and electrotransferred to polyvinylidene difluoride
(PVDF) membrane (Schleicher & Schuell). Membrane
then was blocked with 10 mM Tris–HCl (pH 8.0) and 150
mM NaCl (TBS) containing 10% nonfat milk for 1 h at
room temperature. After blocking, the membrane was
incubated with a 1:1000 dilution of rabbit anti-S anti-
serum (R247 or Cal) in TBS with 0.3% Tween 20 and 5%
nonfat milk for 2 h at room temperature. After incubation,
the membrane was washed four times with TBS and 0.3%
Tween 20. The membrane then was incubated with a
mouse anti-rabbit antibody coupled to horseradish per-
oxidase (Boehringer-Mannheim) in TBS, 0.3% Tween 20
and 5% non-fat milk for 1 h at room temperature. After
extensive washes in TBS and 0.3% Tween 20, immuno-
blots were developed by chemiluminescence after incu-
bation in 100 mM Tris–HCl (pH 8.5) with 225 mM p-
coumaric acid, 1.25 mM 3-aminophtalhydrazide, and
0.03% H2O2, with exposition to Kodak films for detection
of light emission.
Purification of HDV RNA-containing enveloped
particles
PEG-precipitated particles were resuspended in 0.5 ml
of 10 mM Tris–HCl (pH 7.4), 1 mM EDTA, and 150 mM
NaCl (TNE); layered on the top of a 10 to 60% (wt/vol)
CsCl gradient in TNE; and subjected to centrifugation at
35,000 rpm in an SW41 rotor for 16 h at 4°C. After
centrifugation, fractions were collected from the bottom
of the tube, and the density was determined by measure-
ment of the refractive index. An aliquot of each fraction
was used for detection of HDV RNA by agarose gel
electrophoresis and blot hybridization and for detection
of HBsAg by an ELISA (Hepanostika HBsAg Uni-Form II,
Organon Teknika SA) or immunoblot analysis with anti-S
antibodies.
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